Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MBOT
CUSIPN/A
Phone781-875-3605
Debt
Debt-to-Equity RatioN/A
Current Ratio14.31
Quick Ratio14.31
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$120,000.00
Price / Sales149.65
Cash FlowN/A
Price / CashN/A
Book Value$4.06 per share
Price / Book1.51
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-7,580,000.00
Net MarginsN/A
Return on Equity-62.04%
Return on Assets-58.79%
Miscellaneous
Employees7
Outstanding Shares2,920,000
Market Cap$16.77 million
Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions
What is Microbot Medical's stock symbol?
Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."
When did Microbot Medical's stock split? How did Microbot Medical's stock split work?
Microbot Medical shares reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.
How were Microbot Medical's earnings last quarter?
Microbot Medical Inc (NASDAQ:MBOT) announced its quarterly earnings results on Tuesday, August, 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.04). View Microbot Medical's Earnings History.
When is Microbot Medical's next earnings date?
What price target have analysts set for MBOT?
1 equities research analysts have issued 1-year target prices for Microbot Medical's stock. Their predictions range from $1.75 to $1.75. On average, they expect Microbot Medical's stock price to reach $1.75 in the next twelve months. This suggests that the stock has a possible downside of 71.5%. View Analyst Price Targets for Microbot Medical.
What is the consensus analysts' recommendation for Microbot Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Microbot Medical.
Who are some of Microbot Medical's key competitors?
Some companies that are related to Microbot Medical include BioCardia (BCDA), Oncobiologics (ONS), Entera Bio (ENTX), Curis (CRIS), Genocea Biosciences (GNCA), BIONDVAX PHARMA/S (BVXV), Proteon Therapeutics (PRTO), CytRx (CYTR), Vical (VICL), Arsanis (ASNS), aTyr Pharma (LIFE), Vaxart (VXRT), Genetic Technologies (GENE), Neuralstem (CUR) and TrovaGene (TROV).
Who are Microbot Medical's key executives?
Microbot Medical's management team includes the folowing people:
- Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 45)
- Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 66)
- Mr. Yoseph Bornstein, Co-Founder & Director (Age 59)
- Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 49)
- Mr. Yehezkel Himelfarb, COO, GM of Israeli operations & Director (Age 60)
Has Microbot Medical been receiving favorable news coverage?
Media stories about MBOT stock have trended somewhat positive recently, Accern reports. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Microbot Medical earned a news impact score of 0.18 on Accern's scale. They also assigned news stories about the biotechnology company an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term. View Recent Headlines for Microbot Medical.
How do I buy shares of Microbot Medical?
Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Microbot Medical's stock price today?
One share of MBOT stock can currently be purchased for approximately $6.15.
How big of a company is Microbot Medical?
Microbot Medical has a market capitalization of $16.77 million and generates $120,000.00 in revenue each year. Microbot Medical employs 7 workers across the globe.
How can I contact Microbot Medical?
Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]
MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)
MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
